In This Article:
-
Net Sales: $523.2 million, a significant decrease from $801.7 million in the same period last year.
-
Net Income: $17.0 million, or $0.35 per diluted share, down from $198.6 million, or $4.07 per diluted share in the prior year.
-
Dividend: A cash dividend of $0.116 per share will be paid following the company's variable dividend policy.
-
Market Challenges: A substantial drop in the net average selling price for conventional eggs and legal contingencies impacted earnings.
-
Operational Highlights: Slight increase in egg volumes sold and the acquisition of Fassio Egg Farms to boost cage-free egg production.
-
HPAI Impact: An outbreak led to the depopulation of approximately 1.5 million laying hens and 240 thousand pullets.
-
Balance Sheet: Strong cash and short-term investments at $567.8 million, with total assets of $1.96 billion.
On January 3, 2024, Cal-Maine Foods Inc (NASDAQ:CALM) released its 8-K filing, detailing the financial results for the second quarter of fiscal 2024. The company, known for its extensive range of shell eggs, including cage-free and organic options, faced a challenging market environment with significant volatility in egg prices.
Financial Performance and Challenges
Cal-Maine Foods Inc (NASDAQ:CALM) reported a decrease in net sales to $523.2 million compared to $801.7 million in the same period last year. This decline was primarily due to a significant drop in the net average selling price for conventional eggs. Despite the lower prices, the company saw a slight increase in total volumes sold, with 288.2 million dozen eggs sold during the quarter, up 1.4% from the previous year.
The company's net income for the quarter was $17.0 million, or $0.35 per diluted share, a stark contrast to the $198.6 million, or $4.07 per diluted share, reported in the second quarter of fiscal 2023. This decrease in profitability included a $19.6 million loss contingency accrual for a pending anti-trust legal proceeding.
Cal-Maine Foods Inc (NASDAQ:CALM) also faced operational challenges due to the highly pathogenic avian influenza (HPAI), which resulted in the depopulation of a portion of its flock. However, the company believes it can mitigate the loss of production through flock rotations and remains committed to robust biosecurity measures.
Strategic Acquisitions and Outlook
The company completed the acquisition of Fassio Egg Farms, enhancing its cage-free egg production capabilities. Additionally, Cal-Maine Foods announced an agreement to acquire assets from Tyson Foods, which is expected to be completed in the third fiscal quarter, further expanding its production and distribution capabilities.